SLDB
Solid Biosciences Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.92
+7.05%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-55.4%
Return on equity
-49.2%
Return on assets
-53.8%
Return on invested capital
0.00x
Asset turnover
-$186.8M
Cash from operations
$3.52
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026